Alzheimer Disease Clinical Trials in Savannah, Georgia
3 recruitingSavannah, Georgia
Showing 1–3 of 3 trials
Recruiting
Phase 3
A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-1)
Alzheimer Disease
Bristol-Myers Squibb352 enrolled157 locationsNCT07011732
Recruiting
Georgia Memory Net Anti-Amyloid Monoclonal Antibody Registry
Alzheimer Disease
Emory University735 enrolled8 locationsNCT05999084
Recruiting
Phase 2
Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986368, for the Treatment of Agitation in Participants With Alzheimer's Disease
Alzheimer DiseaseAgitation
Celgene120 enrolled52 locationsNCT06808984